- Research works
- 14 ▲ 46% vs 2018-21
- Citations
- 182 12.8 per fractional work
- Top-10% rate
- 9.7% all institutions 10.0%
- Open access
- 15% world 40%
- International
- 38% world 18%
Not ranked overall: TeraRecon (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does TeraRecon (United States) work in?
In all years, 52% of research at TeraRecon (United States) is in Physical Sciences, 34% in Health Sciences. Its largest fields are Computer Science (37%), Medicine (34%), Business, Management and Accounting (7%).
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Physical Sciences751.9%
- Computer Science537.1%
- Engineering16.7%
- Mathematics03.1%
- Physics and Astronomy03.0%
- Chemistry01.3%
- Environmental Science00.8%
- Health Sciences534.0%
- Medicine534.0%
- Social Sciences18.7%
- Life Sciences15.3%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does TeraRecon (United States) publish most on?
By volume in 2022-now: Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors and Click Chemistry and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 3 Protein Degradation and Inhibitors Molecular Biology 0 works
- 4 Click Chemistry and Applications Organic Chemistry 0 works
- 5 Synthesis and biological activity Organic Chemistry 0 works
- 6 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 7 Multiple Myeloma Research and Treatments Hematology 0 works
- 8 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has TeraRecon (United States)'s research output changed?
Output in 2022-2025 was 46% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is TeraRecon (United States) as a percentage of every work published that year, 0.000017% in 2023.
Fractional works of TeraRecon (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Foster City
- Gilead Sciences (United States)
- Visa (United States)
- SciClone Pharmaceuticals (United States)
- Interdisciplinary Dental Education Academy
- Notable Labs (United States)
- Guidewire (United States)
- Apollomics (United States)
- Active Spectrum (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about TeraRecon (United States). Posts are plain text and can be reported.